SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-23-033407
Filing Date
2023-03-16
Accepted
2023-03-16 18:01:32
Documents
2
Period of Report
2023-02-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm239814d1_3.html 3  
1 OWNERSHIP DOCUMENT tm239814d1_3.xml 3 2263
2 EXHIBIT 24 tm239814d1_ex24.htm EX-24 4348
  Complete submission text file 0001104659-23-033407.txt   8122
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Issuer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7 PARKLAND DRIVE MILFORD NJ 08848
Business Address
Shustov Andrei (Reporting) CIK: 0001969686 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36598 | Film No.: 23740071